Valbiotis (XPAR:ALVAL) Days Inventory: 389.80 (As of Dec. 2025) — 85% Below Median


XPAR:ALVAL Valbiotis SA XPAR:ALVAL
55 GF Score
Price €0.80
GF Value €1.49
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Valbiotis Days Inventory?

Valbiotis XPAR:ALVAL +7.38% 55 Days Inventory is 389.80 as of Dec. 2025, which is 85% below its 10-year median of 2,595.56. GuruFocus rates XPAR:ALVAL with a GF Score™ of 55/100 and a GF Value™ of €1.49 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,865 Consumer Packaged Goods companies, Valbiotis ranks worse than 95.66% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Valbiotis's Average Total Inventories for the six months ended in Dec. 2025 was €2.50 Mil. Valbiotis's Cost of Goods Sold for the six months ended in Dec. 2025 was €1.17 Mil. Hence, Valbiotis's Days Inventory for the six months ended in Dec. 2025 was 389.80.

The historical rank and industry rank for Valbiotis's Days Inventory or its related term are showing as below:

XPAR:ALVAL' s Days Inventory Range Over the Past 10 Years
Min: 135.57   Med: 2595.56   Max: 27375
Current: 386.95

During the past 11 years, Valbiotis's highest Days Inventory was 27375.00. The lowest was 135.57. And the median was 2595.56.

XPAR:ALVAL's Days Inventory is ranked worse than
95.66% of 1865 companies
in the Consumer Packaged Goods industry
Industry Median: 82.85 vs XPAR:ALVAL: 386.95

Valbiotis's Days Inventory increased from Dec. 2024 (212.71) to Dec. 2025 (389.80). It might indicate that Valbiotis's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Valbiotis's Inventory Turnover for the six months ended in Dec. 2025 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Valbiotis's Inventory-to-Revenue for the six months ended in Dec. 2025 was 4.36.


Valbiotis  (XPAR:ALVAL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Valbiotis's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Valbiotis's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Valbiotis Days Inventory Related Terms


Valbiotis Days Inventory Historical Data

* Premium members only.

The historical data trend for Valbiotis's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valbiotis Days Inventory Chart

Valbiotis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,360.78 9,621.81 135.57 215.61 372.95

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.55 249.97 212.71 398.55 389.80

XPAR:ALVAL vs KHC, GIS, HRL: Days Inventory Comparison

For the Packaged Foods subindustry, Valbiotis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valbiotis Days Inventory vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Valbiotis's Days Inventory distribution charts can be found below:

* The bar in red indicates where Valbiotis's Days Inventory falls into.


XPAR:ALVAL
55GF Score
Valbiotis SA XPAR:ALVAL
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valbiotis Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Valbiotis's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (2.088 + 2.465) / 2 ) / 2.228*365
=2.2765 / 2.228*365
=372.95

Valbiotis's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (2.533 + 2.465) / 2 ) / 1.17*365 / 2
=2.499 / 1.17*365 / 2
=389.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 389.80 mean?
Valbiotis (XPAR:ALVAL) has a Days Inventory of 389.80 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valbiotis and its competitors. This is 85% below median its historical median of 2,595.56. Over the past decade, Valbiotis' Days Inventory has ranged from 135.57 to 27,375.00. According to the industry distribution chart, Valbiotis ranks #1784 out of 1865 companies in the Consumer Packaged Goods industry, placing it in the top 95.7%.
Is Valbiotis' Days Inventory too high?
Valbiotis' current Days Inventory of 389.80 is 85% below median its 10-year median of 2,595.56. Over the past 10 years, this metric has ranged from a low of 135.57 to a high of 27,375.00. The Consumer Packaged Goods industry median Days Inventory is 82.85. Valbiotis' value of 389.80 is 370.5% above this industry median. Based on the distribution chart, Valbiotis ranks #1784 out of 1865 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Valbiotis has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' Days Inventory compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Valbiotis ranks #1784 out of 1865 companies for Days Inventory. This places Valbiotis in the lower half of its industry. The industry median Days Inventory is 82.85. Valbiotis' value of 389.80 is 370.5% above this benchmark. Historically, Valbiotis' own Days Inventory has ranged from 135.57 to 27,375.00 over the past decade. While the company's 10-year median is 2,595.56 vs. the industry median of 82.85, Valbiotis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 82.85, based on 1,865 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valbiotis's current Days Inventory of 389.80 is 370.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valbiotis and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 82.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valbiotis's current Days Inventory is 389.80, which is 85% below median its own 10-year median of 2,595.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Based on GuruFocus' analysis, Valbiotis (XPAR:ALVAL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.49, compared to a current price of €0.80 — trading 46.3% below its estimated fair value. The current Days Inventory is 389.80, which is 85% below median its 10-year median of 2,595.56 and 370.5% above the Consumer Packaged Goods industry median of 82.85. Valbiotis' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Valbiotis (XPAR:ALVAL), the current Days Inventory is 389.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valbiotis (XPAR:ALVAL) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.80 is trading 46.3% below its estimated GF Value™ of €1.49. GuruFocus considers Valbiotis to be Possible Value Trap.

Key valuation signals for XPAR:ALVAL:

  • Days Inventory: 389.80 (85% below median its 10-year median of 2,595.56)
  • GF Value™: €1.49 vs. price of €0.80 (46.3% below fair value)
  • GF Score™: 55/100 with 6 warning signs
  • Industry Position: 370.5% above the Consumer Packaged Goods median (#1784 of 1865)

No single metric tells the full story. See the XPAR:ALVAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valbiotis Business Description

Other Exchanges 8JD:Germany
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
55GF Score

Get the complete analysis for XPAR:ALVAL

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.80
Price
€1.49
GF Value